Nucleus plus
  • Patient Care
  • About
 
 

12.22.22

Adoptive immunotherapy for AML using CAR.CD123-NK cells

by ASTCT Science Highlights

Caruso S, De Angelis B, Del Bufalo F, et al. Safe and Effective Off-the-Shelf Immunotherapy Based on CAR.CD123-NK Cells for the Treatment of Acute Myeloid Leukaemia. Journal of Hematology & Oncology. 2022; 15 (doi: 10.1186/s13045-022-01376-3).

Researchers have demonstrated the viability of an adoptive immunotherapy strategy for acute myeloid leukemia (AML) that employs natural killer (NK) cells engineered to express anti-CD123+chimeric antigen receptor (CAR). The CD123 antigen is highly present in the leukemia cells of children with AML, but T cell-based immunotherapy is persistently undermined by on-target off-tumor toxicity. In their work, which included two humanized models of AML in immune-deficient mice, investigators observed that CAR.CD123-NK cells boasted a superior safety profile compared with CAR T cells in terms of both hematopoietic and endothelial on-target off-tumor toxicity. They observed that mice infused with CAR.CD123 NK cells survived the experiment, with no associated toxicity, while all of the mice infused with CAR.CD123 T cells developed toxicity against primary human bone marrow cells and perished within five days. The investigational approach also produced an anti-leukemia effect in vitro on par with that achieved by CAR T-cell therapy. The study authors envision using CAR.CD123-NK cells not only for refractory and resistant AML but also possibly for the treatment of other cancers that are difficult to target with the usual T effector cells.

Read More

Calibrating CAR T-cell activation may improve response in solid tumors
03.30.23
Calibrating CAR T-cell activation may improve response in solid tumors
by
BT improves CD19 CAR-T patient outcomes in LBCL
03.28.23
BT improves CD19 CAR-T patient outcomes in LBCL
by ASTCT Science Highlights
DLL3 CAR T appears promising for SCLC treatment
03.21.23
DLL3 CAR T appears promising for SCLC treatment
by ASTCT Science Highlights
footer divider

ASTCT

American Society for Transplantation
and Cellular Therapy

330 North Wabash Avenue, Suite 2000
Chicago, IL 60611, USA
Phone: (312) 321-6820
Fax: (312) 673-6733

facebook youtube twitter linkedin
Login
Search